Shanghai MicroPort MedBot (Group) Co Ltd Sustainability Reports
The company engages in the research, development, manufacture, and commercialization of surgical robotic systems. Its solutions span key medical subsectors including endoscopy, orthopedics, vascular intervention, natural orifice surgery, and percutaneous puncture.
Sector: Manufacturing
Country: China
Exchange: Hong Kong Stock Exchange
FIGI: BBG011DL0RF9
9 reports from 2021 to 2025